George Mason to Combine Proteomics and Biodefense Chops to Study Infectious Diseases | GenomeWeb
NEW YORK (GenomeWeb News) — George Mason University will combine the "expertise" from two of its research centers to use proteomics and molecular biology along with nanotechnology to hunt for blood-borne markers of infectious disease, the University said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.